Choice of initial therapy for hypertension

被引:58
作者
Kaplan, NM
Gifford, RW
机构
[1] UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235
[2] CLEVELAND CLIN FDN,DEPT NEPHROL INTERNAL MED & HYPERTENS,CLEVELAND,OH 44195
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1996年 / 275卷 / 20期
关键词
D O I
10.1001/jama.275.20.1577
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is one of the most common conditions treated by the clinician, yet accurate diagnosis and selection of the appropriate treatment can be challenging and recommendations regarding antihypertensive medications continue to evolve. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure recommends diet and exercise for the initial treatment of mild hypertension, followed by a diuretic or P-blocker if necessary, unless contraindicated. This recommendation is based on outcome studies using these drugs that demonstrate reductions in major diseases that treatment of hypertension is intended to prevent: stroke and cardiovascular morbidity and mortality. Other antihypertensive drugs, while not tested in large trials evaluating outcomes, have unique advantages for certain patients. Consideration of the patient's medical conditions and needs, including the cost of medication, is essential to ensuring optimal treatment of hypertension.
引用
收藏
页码:1577 / 1580
页数:4
相关论文
共 30 条
  • [1] ANGIOEDEMA INDUCED BY THE ANGIOTENSIN-II BLOCKER LOSARTAN
    ACKER, CG
    GREENBERG, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) : 1572 - 1572
  • [2] [Anonymous], 1993, BMJ, V307, P1541
  • [3] A RANDOMIZED CONTROLLED TRIAL OF THE EFFECTS OF 3 ANTIHYPERTENSIVE AGENTS ON BLOOD-PRESSURE CONTROL AND QUALITY-OF-LIFE IN OLDER WOMEN
    APPLEGATE, WB
    PHILLIPS, HL
    SCHNAPER, H
    SHEPHERD, AMM
    SCHOCKEN, D
    LUHR, JC
    KOCH, GG
    PARK, GD
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (09) : 1817 - 1823
  • [4] 1ST-LINE PHARMACOLOGICAL TREATMENT OF HYPERTENSION
    BURNIER, M
    WAEBER, B
    BRUNNER, HR
    [J]. JOURNAL OF INTERNAL MEDICINE, 1992, 232 (05) : 381 - 388
  • [5] CARTER BL, 1989, J FAM PRACTICE, V29, P257
  • [6] A MULTIFACTORIAL TRIAL DESIGN TO ASSESS COMBINATION THERAPY IN HYPERTENSION - TREATMENT WITH BISOPROLOL AND HYDROCHLOROTHIAZIDE
    FRISHMAN, WH
    BRYZINSKI, BS
    COULSON, LR
    DEQUATTRO, VL
    VLACHAKIS, ND
    MROCZEK, WJ
    DUKART, G
    GOLDBERG, JD
    ALEMAYEHU, D
    KOURY, K
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (13) : 1461 - 1468
  • [7] NIFEDIPINE - DOSE-RELATED INCREASE IN MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE
    FURBERG, CD
    PSATY, BM
    MEYER, JV
    [J]. CIRCULATION, 1995, 92 (05) : 1326 - 1331
  • [8] GIFFORD RW, 1989, HYPERTENSION S, V2, P65
  • [9] DOXAZOSIN FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-RESPONSE MULTICENTER STUDY
    GILLENWATER, JY
    CONN, RL
    CHRYSANT, SG
    ROY, J
    GAFFNEY, M
    ICE, K
    DIAS, N
    [J]. JOURNAL OF UROLOGY, 1995, 154 (01) : 110 - 115
  • [10] MANAGEMENT OF RAISED BLOOD-PRESSURE IN NEW-ZEALAND - A DISCUSSION DOCUMENT
    JACKSON, R
    BARHAM, P
    BILLS, J
    BIRCH, T
    MCLENNAN, L
    MACMAHON, S
    MALING, T
    [J]. BRITISH MEDICAL JOURNAL, 1993, 307 (6896) : 107 - 110